Back to Dashboard
EW · Healthcare

Edwards Lifesciences Corp

USA Healthcare Filing: 2026-06-30
30/100
Smart-money confidence1 of 3 sources positive
Below average interest

No standout activity across the feeds we track.

What this band has actually done: stocks scoring 25–45 beat the S&P 500 over the next three months 45.3% of the time, across 39,662 cases since 2015. That is below a coin flip — and so is every other band, because the median stock loses to a cap-weighted index. How we measured this

Hedge funds
40
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s.  ·  how the score works
Market cap
$49.4B
Industry
Medical Devices
Sector
Healthcare
Exchange
NYSE
About EDWARDS LIFESCIENCES CORP

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name;…

Who's behind the signal
Every informed buyer we can see on EW, across all three feeds.
Hedge funds · 8
Citadel Advisors Increased +670%
Baillie Gifford & Co Increased +175%
Point72 (Steve Cohen) Decreased −3%
AQR Capital Management Decreased −26%
+2 more in the full breakdown below ↓
Congress · 11
Mike Kelly sold
+3 more in the full record below ↓
Insiders
No significant Form 4 insider activity in the window.
Congressional trades · 22 on record
Disclosures from 2020-03-23 to 2026-03-27
Trade date Member Chamber Action Amount
2026-03-27 Alan Armstrong · R-OK Senate Bought $1,001 - $15,000
2025-11-19 Josh Gottheimer · D-NJ House Sold $1,001 - $15,000
2025-05-12 Jefferson Shreve · R-IN House Sold $50,001 - $100,000
2025-04-21 Bruce Westerman · R-AR House Sold $1,001 - $15,000
2025-04-08 Robert P. Bresnahan, Jr. · R-PA House Bought $1,001 - $15,000
2025-04-07 Jefferson Shreve · R-IN House Bought $15,001 - $50,000
2025-03-03 Bruce Westerman · R-AR House Bought $1,001 - $15,000
2024-04-11 Mike Kelly · R-PA House Sold $1,001 - $15,000
2023-12-11 Josh Gottheimer · D-NJ House Bought $1,001 - $15,000
2023-12-04 John R. Curtis · R-UT House Sold $1,001 - $15,000
Show the other 12
Trade date Member Chamber Action Amount
2023-06-21 John R. Curtis · R-UT House Bought $1,001 - $15,000
2023-05-25 Zoe Lofgren · D-CA House Sold $1,001 - $15,000
2023-04-26 John R. Curtis · R-UT House Bought $1,001 - $15,000
2023-03-06 Daniel S. Goldman · D-NY House Bought $15,001 - $50,000
2021-09-16 Katherine M. Clark · D-MA House Sold $1,001 - $15,000
2021-09-02 Zoe Lofgren · D-CA House Bought $1,001 - $15,000
2021-08-09 Zoe Lofgren · D-CA House Bought $1,001 - $15,000
2021-07-27 Katherine M. Clark · D-MA House Sold $1,001 - $15,000
2021-02-16 Peter Meijer · R-MI House Sold $1,001 - $15,000
2021-01-28 Peter Meijer · R-MI House Sold $1,001 - $15,000
2020-11-05 Katherine M. Clark · D-MA House Bought $1,001 - $15,000
2020-03-23 Zoe Lofgren · D-CA House Sold $1,001 - $15,000
Not a model pick — but on our radar. EDWARDS LIFESCIENCES CORP isn't in the top-10 model right now, but 8 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
8
Investors
0
New positions
4
Increasing
4
Decreasing
0
Unchanged
Price History
Loading price data...
A member of Congress bought A member sold
Return: High: Low:

Markers sit on the transaction date the member disclosed, snapped to the nearest close on the chart. They are not the date the public found out — that came later, and the gap is its own page. Every marker is listed by name in the table above.

Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Portfolio Allocation
How much of each investor's portfolio is allocated to EDWARDS LIFESCIENCES CORP
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell EDWARDS LIFESCIENCES CORP or any security.

Get the Weekly Update

Every week, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime